mail
versión imprimible
 
 

6th Obesity and NASH Drug Development Summit 2022

Evvnt Promotion / evvnt
-
29.11.2022 - 01.12.2022  Revere Hotel Boston Common, 200 Stuart Street, 02116 Boston, Massachusetts, USA
Time: 09:55 - 16:40
 
Temas de la conferencia
The first wave of investment in NASH is dispersing in the wake of highly demanding biopsy endpoints, but opportunities to target obesity and metabolic syndrome are catalyzing increasing excitement. Pivotal readouts in GLP-1 receptor agonists and exciting progress in regenerative medicine and microRNAs are redefining the drug development landscape for metabolic disorders.
Organizador profesional (PCO)
Hanson Wade
Observaciones
Brochure: https://go.evvnt.com/1277295-3?pid=4832

Speakers: Allison Goldfine, Director, Translational Medicine Cardiometabolic Disease, Novartis, Andrew Billin, Senior Director Biomarker Sciences, Gilead, and more.
 

Información e inscripción:

https://go.evvnt.com/1277295-2?pid=4832
Ms. Jessica Durston
 
Categorías
Medicina General
Idioma
Inglés
Cuota del Congreso
USD 2599.00 - USD 5097.00
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

Alumni Club Medizinische Universität WienEuropean Health Forum GasteinÄrzte der WeltSwiss Tropical and Public Health InstituteHelix - Forschung & Beratung WienCenter of ExcellenceÖsterreichische Gesellschaft für Public HealthHilfswerk Austria